We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
(-17%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 18.25% |
| 3 | Consumer Discretionary | 14.02% |
| 4 | Industrials | 10.23% |
| 5 | Financials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMD
901
DELISTED
Cantel Medical Corporation
CMD
| $5.86M | 0.01% |
78,647
-86,894
| -52% | -$7.17M |
|
902
Unifirst Corp
UNF
$5.24B
| $5.83M | 0.01% |
40,717
-13,668
| -25% | -$2.04M |
|
903
Buckle
BKE
$2.39B
| $5.82M | 0.01% |
300,880
+41,695
| +16% | +$845K |
|
904
Xylem
XYL
$28.5B
| $5.74M | 0.01% |
86,002
-23,226
| -21% | -$1.61M |
|
|
BFX
905
DELISTED
BowFlex Inc.
BFX
| $5.74M | 0.01% |
526,299
-7,656
| -1% | -$95.7K |
|
906
Hackett Group
HCKT
$286M
| $5.71M | 0.01% |
356,894
-7,622
| -2% | -$142K |
|
907
Interface
TILE
$2.21B
| $5.68M | 0.01% |
398,773
-83,239
| -17% | -$1.43M |
|
908
Boot Barn
BOOT
$5.17B
| $5.68M | 0.01% |
333,333
+108,760
| +48% | +$2.5M |
|
|
VRNT
909
DELISTED
Verint Systems
VRNT
| $5.67M | 0.01% |
263,293
+3,928
| +2% | +$90.3K |
|
910
Morningstar
MORN
$7.67B
| $5.66M | 0.01% |
51,551
+34,269
| +198% | +$4.02M |
|
|
SYKE
911
DELISTED
SYKES Enterprises Inc
SYKE
| $5.65M | 0.01% |
228,327
-56,173
| -20% | -$1.57M |
|
912
Stoneridge
SRI
$206M
| $5.64M | 0.01% |
228,634
-87,112
| -28% | -$2.21M |
|
913
HUB Group
HUBG
$2.93B
| $5.63M | 0.01% |
303,742
-162,442
| -35% | -$3.48M |
|
914
Independent Bank Corp
IBCP
$834M
| $5.59M | 0.01% |
266,014
-167,853
| -39% | -$3.78M |
|
915
Rocky Brands
RCKY
$368M
| $5.58M | 0.01% |
214,491
+14,166
| +7% | +$366K |
|
916
ONE Gas
OGS
$4.99B
| $5.57M | 0.01% |
69,923
-32,734
| -32% | -$2.7M |
|
917
Marriott Vacations Worldwide
VAC
$3.97B
| $5.55M | 0.01% |
78,740
+49,106
| +166% | +$4.09M |
|
918
FirstCash
FCFS
$9.07B
| $5.55M | 0.01% |
76,650
-11,203
| -13% | -$893K |
|
919
Fomento Económico Mexicano
FMX
$41.2B
| $5.49M | 0.01% |
63,809
-17,565
| -22% | -$1.56M |
|
920
Fabrinet
FN
$19.2B
| $5.46M | 0.01% |
106,312
+98,990
| +1,352% | +$4.74M |
|
921
DuPont de Nemours
DD
$19.2B
| $5.42M | 0.01% |
40,039
-1,469
| -4% | -$211K |
|
922
Cathay General Bancorp
CATY
$4.21B
| $5.39M | 0.01% |
160,770
-16,290
| -9% | -$617K |
|
923
Sturm, Ruger & Co
RGR
$593M
| $5.38M | 0.01% |
101,188
+35,080
| +53% | +$2.02M |
|
924
Integer Holdings
ITGR
$4.25B
| $5.32M | 0.01% |
69,806
+13,139
| +23% | +$1.05M |
|
925
Sabre
SABR
$831M
| $5.3M | 0.01% |
244,817
+39,947
| +19% | +$967K |
|
Similar funds
VGA
AQR Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
- AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
- AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.